<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39383163</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>10</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Risk of death in England following a positive SARS-CoV-2 test: A retrospective national cohort study (March 2020 to September 2022).</ArticleTitle><Pagination><StartPage>e0304110</StartPage><MedlinePgn>e0304110</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0304110</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0304110</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">We aimed to estimate the relative risk of mortality following a first positive SARS-CoV-2 test during the first, second, and third waves of the COVID-19pandemic in England by age, sex, and vaccination status, taking into account pre-existing health conditions and lifestyle factors.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a retrospective cohort study of all individuals registered with the National Health Service (NHS) in England from 1 March 2020 to September 2022. Data for all individuals were obtained and linked including primary care records, hospital admission episodes, SARS-CoV-2 test results, vaccinations, and death registrations. We fitted Cox Proportional Hazards models with time dependent covariates for confirmed SARS-CoV-2 infection to model the risk of subsequent mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The hazard ratio for death after testing positive for subsequent, compared with those not testing positive, amongst unvaccinated individuals, ranged from 11 to 89 by age and sex, in the first four weeks following a positive test in wave one and reduced to 14 to 50 in wave three. This hazard was further reduced amongst those who had three vaccines to between 1.4 and 7 in wave three.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study provides robust estimates of increased mortality risk among those who tested positive over the first three waves of the COVID-19 pandemic in England. The estimates show the impact of various factors affecting the risk of mortality from COVID-19. The results provide the first step towards estimating the magnitude and pattern of mortality displacement due to COVID-19, which is essential to understanding subsequent mortality rates in England.</AbstractText><CopyrightInformation>Copyright: © 2024 Bauer-Staeb et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bauer-Staeb</LastName><ForeName>Clarissa</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Office for Health Improvement and Disparities, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holleyman</LastName><ForeName>Richard James</ForeName><Initials>RJ</Initials><Identifier Source="ORCID">0000-0001-9748-7932</Identifier><AffiliationInfo><Affiliation>UK Health Security Agency, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barnard</LastName><ForeName>Sharmani</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Population Health, Curtin University, Bentley, Western Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hughes</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Office for Health Improvement and Disparities, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dunn</LastName><ForeName>Samantha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Office for Health Improvement and Disparities, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fox</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Office for Health Improvement and Disparities, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fitzpatrick</LastName><ForeName>Justine</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Office for Health Improvement and Disparities, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Newton</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Office for Health Improvement and Disparities, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fryers</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Office for Health Improvement and Disparities, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burton</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldblatt</LastName><ForeName>Peter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-0491-2077</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology &amp; Public Health, UCL Institute of Health Equity, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004739" MajorTopicYN="N" Type="Geographic">England</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>PG declares consultancy payments made from OHID to UCL Consulting to support the preparation of this manuscript. All other authors have no declarations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>22</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>22</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>13</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39383163</ArticleId><ArticleId IdType="pmc">PMC11463829</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0304110</ArticleId><ArticleId IdType="pii">PONE-D-23-38124</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Department of Health and Social Care. Excess mortality in England and English regions. In: GOV.UK [Internet]. 9
Mar
2023.  [cited 18 Mar 2023]. Available: https://www.gov.uk/government/statistics/excess-mortality-in-england-and-english-regions</Citation></Reference><Reference><Citation>Hippisley-Cox J, Coupland CA, Mehta N, Keogh RH, Diaz-Ordaz K, Khunti K, et al.. Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study. BMJ. 2021;374: n2244. doi: 10.1136/bmj.n2244</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n2244</ArticleId><ArticleId IdType="pmc">PMC8446717</ArticleId><ArticleId IdType="pubmed">34535466</ArticleId></ArticleIdList></Reference><Reference><Citation>Clift AK, Coupland CAC, Keogh RH, Diaz-Ordaz K, Williamson E, Harrison EM, et al.. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study. BMJ. 2020;371: m3731. doi: 10.1136/bmj.m3731</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3731</ArticleId><ArticleId IdType="pmc">PMC7574532</ArticleId><ArticleId IdType="pubmed">33082154</ArticleId></ArticleIdList></Reference><Reference><Citation>Maynou L, Owen R, Konstant-Hambling R, Imam T, Arkill S, Bertfield D, et al.. The association between frailty risk and COVID-19-associated all-mortality in hospitalised older people: a national cohort study. Eur Geriatr Med. 2022;13: 1149–1157. doi: 10.1007/s41999-022-00668-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41999-022-00668-8</ArticleId><ArticleId IdType="pmc">PMC9244480</ArticleId><ArticleId IdType="pubmed">35750959</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikolai J, Dorey P, Keenan K, Kulu H. Spatial patterns of COVID-19 and non-COVID-19 mortality across waves of infection in England, Wales, and Scotland. Social Science &amp; Medicine. 2023;338: 116330. doi: 10.1016/j.socscimed.2023.116330</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2023.116330</ArticleId><ArticleId IdType="pubmed">37907058</ArticleId></ArticleIdList></Reference><Reference><Citation>Strongman H, Carreira H, Stavola BLD, Bhaskaran K, Leon DA. Factors associated with excess all-cause mortality in the first wave of the COVID-19 pandemic in the UK: A time series analysis using the Clinical Practice Research Datalink. PLOS Medicine. 2022;19: e1003870. doi: 10.1371/journal.pmed.1003870</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003870</ArticleId><ArticleId IdType="pmc">PMC8735664</ArticleId><ArticleId IdType="pubmed">34990450</ArticleId></ArticleIdList></Reference><Reference><Citation>Cusinato M, Gates J, Jajbhay D, Planche T, Ong YE. Increased risk of death in COVID-19 hospital admissions during the second wave as compared to the first epidemic wave: a prospective, single-centre cohort study in London, UK. Infection. 2022;50: 457–465. doi: 10.1007/s15010-021-01719-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01719-1</ArticleId><ArticleId IdType="pmc">PMC8529375</ArticleId><ArticleId IdType="pubmed">34674158</ArticleId></ArticleIdList></Reference><Reference><Citation>Nafilyan V, Humberstone B, Mehta N, Diamond I, Coupland C, Lorenzi L, et al.. An external validation of the QCovid risk prediction algorithm for risk of mortality from COVID-19 in adults: a national validation cohort study in England. The Lancet Digital Health. 2021;3: e425–e433. doi: 10.1016/S2589-7500(21)00080-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(21)00080-7</ArticleId><ArticleId IdType="pmc">PMC8148652</ArticleId><ArticleId IdType="pubmed">34049834</ArticleId></ArticleIdList></Reference><Reference><Citation>Hippisley-Cox J, Khunti K, Sheikh A, Nguyen-Van-Tam JS, Coupland CA. QCovid 4—Predicting risk of death or hospitalisation from COVID-19 in adults testing positive for SARS-CoV-2 infection during the Omicron wave in England. medRxiv; 2022. p. 2022.08.13. doi: 10.1101/2022.08.13.22278733</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.13.22278733</ArticleId><ArticleId IdType="pmc">PMC10282241</ArticleId><ArticleId IdType="pubmed">37343968</ArticleId></ArticleIdList></Reference><Reference><Citation>Holleyman RJ, Barnard S, Bauer-Staeb C, Hughes A, Dunn S, Fox S, et al.. Adjusting expected deaths for mortality displacement during the COVID-19 pandemic: a model based counterfactual approach at the level of individuals. BMC Med Res Methodol. 2023;23: 241. doi: 10.1186/s12874-023-01984-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-023-01984-8</ArticleId><ArticleId IdType="pmc">PMC10585864</ArticleId><ArticleId IdType="pubmed">37853353</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics. Excess mortality and mortality displacement in England and Wales—Office for National Statistics. [cited 18 Mar 2023]. Available: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/articles/excessmortalityandmortalitydisplacementinenglandandwales/2020tomid2021</Citation></Reference><Reference><Citation>UK Government. About the Data—Coronavirus (COVID-19) in the UK. [cited 6 Sep 2022]. Available: https://coronavirus.data.gov.uk</Citation></Reference><Reference><Citation>NHS Digital. Hospital Episode Statistics (HES). In: NHS Digital [Internet]. [cited 8 Nov 2022]. Available: https://digital.nhs.uk/data-and-information/data-tools-and-services/data-services/hospital-episode-statistics</Citation></Reference><Reference><Citation>NHS Digital. General Practice Extraction Service (GPES) Data for pandemic planning and research: a guide for analysts and users of the data. In: NHS Digital [Internet]. [cited 8 Nov 2022]. Available: https://digital.nhs.uk/coronavirus/gpes-data-for-pandemic-planning-and-research/guide-for-analysts-and-users-of-the-data</Citation></Reference><Reference><Citation>NHS England. National Vaccination Programmes. [cited 27 Mar 2023]. Available: https://www.england.nhs.uk/contact-us/privacy-notice/national-flu-vaccination-programme/#immunisation</Citation></Reference><Reference><Citation>Ministry of Housing Communities and Local Government. The English Indices of Deprivation 2019: Research report.
2019; 1–86. Available: https://www.gov.uk/government/publications/english-indices-of-deprivation-2019-technical-report%0Ahttps://www.gov.uk/government/publications/english-indices-of-deprivation-2019-technical-report%0Ahttps://assets.publishing.service.gov.uk/government/uploads
</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>SNOMED International. SNOMED-CT. [cited 18 Mar 2023]. Available: https://www.snomed.org</Citation></Reference><Reference><Citation>UK Parliament. The Health Service (Control of Patient Information) Regulations
2002. Queen’s Printer of Acts of Parliament; [cited 8 Nov 2022]. Available: https://www.legislation.gov.uk/uksi/2002/1438/regulation/3/made</Citation></Reference><Reference><Citation>van Bunnik BAD, Morgan ALK, Bessell PR, Calder-Gerver G, Zhang F, Haynes S, et al.. Segmentation and shielding of the most vulnerable members of the population as elements of an exit strategy from COVID-19 lockdown. Philosophical Transactions of the Royal Society B: Biological Sciences. 2021;376: 20200275. doi: 10.1098/rstb.2020.0275</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rstb.2020.0275</ArticleId><ArticleId IdType="pmc">PMC8165590</ArticleId><ArticleId IdType="pubmed">34053266</ArticleId></ArticleIdList></Reference><Reference><Citation>Msemburi W, Karlinsky A, Knutson V, Aleshin-Guendel S, Chatterji S, Wakefield J. The WHO estimates of excess mortality associated with the COVID-19 pandemic. Nature. 2023;613: 130–137. doi: 10.1038/s41586-022-05522-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05522-2</ArticleId><ArticleId IdType="pmc">PMC9812776</ArticleId><ArticleId IdType="pubmed">36517599</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandula S, Keyes KM, Yaari R, Shaman J. Excess Mortality in the United States, 2020–21: County-level Estimates for Population Groups and Associations with Social Vulnerability. medRxiv. 2024; 2024.01.14.24301290. doi: 10.1101/2024.01.14.24301290</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2024.01.14.24301290</ArticleId><ArticleId IdType="pmc">PMC10827264</ArticleId><ArticleId IdType="pubmed">38293208</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacomelli A, Ridolfo AL, Pezzati L, Oreni L, Carrozzo G, Beltrami M, et al.. Mortality rates among COVID-19 patients hospitalised during the first three waves of the epidemic in Milan, Italy: A prospective observational study. PLOS ONE. 2022;17: e0263548. doi: 10.1371/journal.pone.0263548</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0263548</ArticleId><ArticleId IdType="pmc">PMC9000097</ArticleId><ArticleId IdType="pubmed">35404963</ArticleId></ArticleIdList></Reference><Reference><Citation>Roso-Llorach A, Serra-Picamal X, Cos FX, Pallejà-Millán M, Mateu L, Rosell A, et al.. Evolving mortality and clinical outcomes of hospitalized subjects during successive COVID-19 waves in Catalonia, Spain. Global Epidemiology. 2022;4: 100071. doi: 10.1016/j.gloepi.2022.100071</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gloepi.2022.100071</ArticleId><ArticleId IdType="pmc">PMC8739818</ArticleId><ArticleId IdType="pubmed">35018339</ArticleId></ArticleIdList></Reference><Reference><Citation>Strålin K, Wahlström E, Walther S, Bennet-Bark AM, Heurgren M, Lindén T, et al.. Mortality trends among hospitalised COVID-19 patients in Sweden: A nationwide observational cohort study. The Lancet Regional Health–Europe. 2021;4. doi: 10.1016/j.lanepe.2021.100054</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100054</ArticleId><ArticleId IdType="pmc">PMC7907732</ArticleId><ArticleId IdType="pubmed">33997829</ArticleId></ArticleIdList></Reference><Reference><Citation>Piroth L, Cottenet J, Mariet A-S, Bonniaud P, Blot M, Tubert-Bitter P, et al.. Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study. The Lancet Respiratory Medicine. 2021;9: 251–259. doi: 10.1016/S2213-2600(20)30527-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30527-0</ArticleId><ArticleId IdType="pmc">PMC7832247</ArticleId><ArticleId IdType="pubmed">33341155</ArticleId></ArticleIdList></Reference><Reference><Citation>Urdiales T, Dernie F, Català M, Prats-Uribe A, Prats C, Prieto-Alhambra D. Association between ethnic background and COVID-19 morbidity, mortality and vaccination in England: a multistate cohort analysis using the UK Biobank. BMJ Open. 2023;13: e074367. doi: 10.1136/bmjopen-2023-074367</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2023-074367</ArticleId><ArticleId IdType="pmc">PMC10514643</ArticleId><ArticleId IdType="pubmed">37734898</ArticleId></ArticleIdList></Reference><Reference><Citation>Nab L, Parker EPK, Andrews CD, Hulme WJ, Fisher L, Morley J, et al.. Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platform. The Lancet Public Health. 2023;8: e364–e377. doi: 10.1016/S2468-2667(23)00079-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(23)00079-8</ArticleId><ArticleId IdType="pmc">PMC10139026</ArticleId><ArticleId IdType="pubmed">37120260</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward IL, Bermingham C, Ayoubkhani D, Gethings OJ, Pouwels KB, Yates T, et al.. Risk of covid-19 related deaths for SARS-CoV-2 omicron (B.1.1.529) compared with delta (B.1.617.2): retrospective cohort study. BMJ. 2022;378: e070695. doi: 10.1136/bmj-2022-070695</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-070695</ArticleId><ArticleId IdType="pmc">PMC9344192</ArticleId><ArticleId IdType="pubmed">35918098</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyberg T, Ferguson NM, Nash SG, Webster HH, Flaxman S, Andrews N, et al.. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. The Lancet. 2022;399: 1303–1312. doi: 10.1016/S0140-6736(22)00462-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00462-7</ArticleId><ArticleId IdType="pmc">PMC8926413</ArticleId><ArticleId IdType="pubmed">35305296</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, Saikia D, Bankar M, Saurabh MK, Singh H, Varikasuvu SR, et al.. Efficacy of COVID-19 vaccines: a systematic review and network meta-analysis of phase 3 randomized controlled trials. Pharmacol Rep. 2022;74: 1228–1237. doi: 10.1007/s43440-022-00429-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43440-022-00429-1</ArticleId><ArticleId IdType="pmc">PMC9640819</ArticleId><ArticleId IdType="pubmed">36342658</ArticleId></ArticleIdList></Reference><Reference><Citation>Ssentongo P, Ssentongo AE, Voleti N, Groff D, Sun A, Ba DM, et al.. SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis. BMC Infectious Diseases. 2022;22: 439. doi: 10.1186/s12879-022-07418-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07418-y</ArticleId><ArticleId IdType="pmc">PMC9077344</ArticleId><ArticleId IdType="pubmed">35525973</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng C, Shao W, Chen X, Zhang B, Wang G, Zhang W. Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis. International Journal of Infectious Diseases. 2022;114: 252–260. doi: 10.1016/j.ijid.2021.11.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.11.009</ArticleId><ArticleId IdType="pmc">PMC8595975</ArticleId><ArticleId IdType="pubmed">34800687</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics (ONS).
COVID-19 vaccine effectiveness estimated using Census 2021 variables, England: 31 March 2021 to 20 March 2022.
2023. 
Mar. Available: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/covid19vaccineeffectivenessestimatedusingcensus2021variablesengland/31march2021to20march2022#cite-this-statistical-bulletin</Citation></Reference><Reference><Citation>Office for National Statistics (ONS). Deaths involving COVID-19 by vaccination status, England: deaths occurring between 1 April 2021 and 31 May 2023.
2023. 
Aug. Available: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsinvolvingcovid19byvaccinationstatusengland/deathsoccurringbetween1april2021and31may2023</Citation></Reference><Reference><Citation>Rypdal M, Rypdal K, Løvsletten O, Sørbye SH, Ytterstad E, Bianchi FM. Estimation of Excess Mortality and Years of Life Lost to COVID-19 in Norway and Sweden between March and November 2020. Int J Environ Res Public Health. 2021;18: 3913. doi: 10.3390/ijerph18083913</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18083913</ArticleId><ArticleId IdType="pmc">PMC8068261</ArticleId><ArticleId IdType="pubmed">33917872</ArticleId></ArticleIdList></Reference><Reference><Citation>NHS Digital. Mortality data review. In: Mortality data review [Internet]. [cited 27 Mar 2023]. Available: https://digital.nhs.uk/coronavirus/coronavirus-data-services-updates/mortality-data-review</Citation></Reference><Reference><Citation>Uusküla A, Jürgenson T, Pisarev H, Kolde R, Meister T, Tisler A, et al.. Long-term mortality following SARS-CoV-2 infection: A national cohort study from Estonia. The Lancet Regional Health–Europe. 2022;18. doi: 10.1016/j.lanepe.2022.100394</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2022.100394</ArticleId><ArticleId IdType="pmc">PMC9051903</ArticleId><ArticleId IdType="pubmed">35505834</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>